Authors
Loading...
Pharmacological assays demonstrate that cannabidiol and oleocanthal synergistically enhance TRPA1 activation in inflammation and seizure models, suggesting new treatment avenues.
Dadiotis et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: